About SyzOnc. SyzOnc is an early-stage, preclinical, AI-enabled platform and therapeutics discovery company targeting the solid tumor ecosystem. Our target and drug discovery platform identifies new powerful targets, validates them in proprietary tumor ecosystem & animal models, and uses AI tools. to identify hit small molecules. Founded in 2023 by experts from the Broad Institute and UPenn, we are supported by the American Cancer Society, the NC...
